Log in to search using one of your social media accounts:

This page shows you the latest news items in this category. This is page number 10.

New biosimilar version of arthritis drug etanercept launches in UK
An affordable new therapy option for people with various forms of arthritis has been launched in the UK.Benepali is the first biosimilar version of the established anti-TNF therapy etanercept to be released in Britain, following its approval by the European Commission last month. Its availability is expected to expand access to anti-TNF therapy and ensure patients can be treated more cost-effectively.How Benepali works Biosimilars are a class of drugs that function as near-identical copies of established products that are already available on the market. They seek to replicate the effects and function of the reference prod...
Source: Arthritis Research UK - February 19, 2016 Category: Rheumatology Source Type: news

RheumNow: It Took Me 30 Years to Learn This About RA
(MedPage Today) -- Jack Cush, MD, shares insights into rheumatoid arthritis (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - February 18, 2016 Category: Primary Care Source Type: news

Compound in green tea 'could help block effects of rheumatoid arthritis'
This study has opened the field of research into using EGCG for targeting TAK1 - an important signalling protein - through which proinflammatory cytokines transmit their signals to cause inflammation and tissue destruction in rheumatoid arthritis."The Arthritis Research UK view Richard Francis, head of research liaison and evaluation at Arthritis Research UK, said: "It is known that green tea contains antioxidants and this study shows that the specific EGCG molecule found in green tea can have anti-inflammatory effects."This is interesting research; however, it is still in the early stages, and further resea...
Source: Arthritis Research UK - February 18, 2016 Category: Rheumatology Source Type: news

Could THIS hot drink help ease the agony of rheumatoid arthritis?
A WONDER compound found in green tea could alleviate the agony of rheumatoid arthritis, a new study suggests. (Source: Daily Express - Health)
Source: Daily Express - Health - February 17, 2016 Category: Consumer Health News Source Type: news

Evidence for Treating Rheumatoid Arthritis to TargetEvidence for Treating Rheumatoid Arthritis to Target
When managing rheumatoid arthritis, does a treat-to-target approach convey better outcomes than routine care? Annals of the Rheumatic Diseases (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - February 17, 2016 Category: Orthopaedics Tags: Rheumatology Journal Article Source Type: news

Medical News Today: Green tea compound shows promise for treating rheumatoid arthritis
EGCG - a compound abundant in green tea - was found to reduce ankle swelling in mouse models of rheumatoid arthritis, suggesting it could be a promising treatment for the disease. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - February 17, 2016 Category: Consumer Health News Tags: Arthritis / Rheumatology Source Type: news

What Really Killed Glenn Frey
When Glenn Frey, a co-founder and driving force behind ’70s supergroup the Eagles, died on January 18, I wasn’t just saddened by the loss. I was deeply concerned about the manner of his death. News reports said Frey died from a combination of “complications” from rheumatoid arthritis (RA), one of the most debilitating chronic diseases. RA is an inflammatory autoimmune condition. It affects the entire body — particularly the joints. The body develops antibodies against its own joint tissues, breaking them down. A modern inflammatory diet, genetic factors and food allergies all play a role in developing RA. Enviro...
Source: Al Sears, MD Natural Remedies - February 16, 2016 Category: Complementary Medicine Authors: Al Sears Tags: Men's Health arthritis inflammation vitamin D3 Vitamin K2 Source Type: news

Rheumatoid Arthritis Year in Review
(MedPage Today) -- Coverage from the Rheumatology Winter Clinical Symposia (Source: MedPage Today Geriatrics)
Source: MedPage Today Geriatrics - February 16, 2016 Category: Geriatrics Source Type: news

Impact of Certolizumab Pegol in Rheumatoid ArthritisImpact of Certolizumab Pegol in Rheumatoid Arthritis
This study takes a look at patient-reported outcomes as well as clinical measures of disease activity. Arthritis Research & Therapy (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 16, 2016 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

The Genetics of Rheumatoid ArthritisThe Genetics of Rheumatoid Arthritis
This review examines the genetic and environmental risk factors that influence the development of rheumatoid arthritis. Rheumatology (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - February 16, 2016 Category: Orthopaedics Tags: Rheumatology Journal Article Source Type: news

Cardiac Risks High in Systemic Sclerosis (CME/CE)
(MedPage Today) -- Equivalent to the risks in rheumatoid arthritis (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - February 15, 2016 Category: Cardiology Source Type: news

UK MHRA approves clinical trial of JHL biosimilar to treat RA
The UK's Medicines and Healthcare Products Regulatory Agency (MHRA) has approved a Phase I clinical trial of JHL1101, a potential treatment for rheumatoid arthritis (RA). (Source: Drug Development Technology)
Source: Drug Development Technology - February 15, 2016 Category: Pharmaceuticals Source Type: news

Sandoz buys rights to Pfizer’s infliximab biosimilar in EEA
Novartis' generic pharmaceuticals division Sandoz has acquired rights of Pfizer's PF-06438179, a biosimilar of Merck's Remicade (infliximab), in the European Economic Area (EEA), to treat a range of autoimmune diseases including rheumatoid arthritis … (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - February 15, 2016 Category: Pharmaceuticals Source Type: news

Textile workers at higher risk for rheumatoid arthritis
(Reuters Health) - Breathing textile dust on the job is linked to an almost tripled risk of developing rheumatoid arthritis, an immune system disorder that causes debilitating swelling and pain in the joints, a Malaysian study suggests. (Source: Reuters: Health)
Source: Reuters: Health - February 11, 2016 Category: Consumer Health News Tags: healthNews Source Type: news

Women's Secrets: Clues to a Female Brain?
I was sitting on the train yesterday and couldn't help eavesdropping on the two women sitting in front of me. They looked about 40-something, casually dressed, and from outward appearance rather healthy. Then they started talking about how they're cope with their ailments. One woman has epilepsy and talked about raising a toddler when she worries she may drop her if she seizes, and how she can no longer drive and has to rely on other people to chauffer them around. She also said that because her husband is working crazy hours and she needs a solid night's sleep, they sleep in separate beds during the week. The other woman...
Source: Science - The Huffington Post - February 11, 2016 Category: Science Source Type: news

Anti-TNF therapy linked to ‘modest’ extra SCC risk
A Swedish population-based study shows that treatment with tumour necrosis factor inhibitors significantly increases the risk of developing squamous cell carcinoma, but not basal cell carcinoma, in patients with rheumatoid arthritis. (Source: MedWire News)
Source: MedWire News - February 11, 2016 Category: Consumer Health News Tags: Oncology Source Type: news

Total Cost of Care Will Define Value Propositions
As they move increasingly toward a value-based model, health care systems are also being expected to take on more risk, so every contributor to the total cost of care will increasingly be scrutinized in terms of the value that it brings. Now, life science business leaders have an unrivalled opportunity to learn from senior clinicians and healthcare administrators exactly how these latest trends in the US healthcare landscape are set to impact their commercial organizations. During an extensive live Q&A session on Friday, February 12, three senior healthcare experts will provide privileged insight into “How 2016 Healt...
Source: EyeForPharma - February 9, 2016 Category: Pharmaceuticals Authors: Nick de Cent Source Type: news

Natural protein points to new inflammation treatment
Findings may offer insight to effective treatments for inflammatory diseases, such as rheumatoid arthritis, psoriasis, and multiple sclerosis. (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - February 4, 2016 Category: American Health Source Type: news

Baricitinib for the Treatment of Moderate to Severe Rheumatoid Arthritis
Baricitinib is the first once-daily oral selective JAK1 and JAK2 inhibitor for the treatment of moderate to severe active rheumatoid arthritis (RA). (Source: Drug Development Technology)
Source: Drug Development Technology - February 4, 2016 Category: Pharmaceuticals Source Type: news

Dietary Fatty Acids and Fish Oil for the Treatment of OADietary Fatty Acids and Fish Oil for the Treatment of OA
In rheumatoid arthritis, higher doses of fish oil have been associated with pain reduction in the number of tender joints, but what does fish oil do for osteoarthritis patients? Annals of the Rheumatic Diseases (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - February 3, 2016 Category: Orthopaedics Tags: Rheumatology Journal Article Source Type: news

Highlights from 2015
Your achievements A massive thank you to everyone who ran, hosted coffee mornings and bake sales, jumped out of planes and trekked across the country and indeed the world to fundraise for us. More than 1,300 of you took on a challenge or donated your time and fundraising skills in 2015. Together, you raised over £780,000! If you’d like to join Team A in 2016 and help raise money for our work, have a look at our events or contact localfundraising@arthritisresearchuk.org Improving care for people with arthritis In 2015 we continued to support healthcare professionals to provide the best care to people with art...
Source: Arthritis Research UK - February 3, 2016 Category: Rheumatology Source Type: news

Strategies to Predict RA Development in At-Risk PopulationsStrategies to Predict RA Development in At-Risk Populations
How can we predict the risk of rheumatoid arthritis in the various preclinical stages? Rheumatology (Source: Medscape Orthopaedics Headlines)
Source: Medscape Orthopaedics Headlines - February 2, 2016 Category: Orthopaedics Tags: Rheumatology Journal Article Source Type: news

Many Factors Play into Increased Heart Disease Risk for Those with RA
In honor of Rheumatoid Arthritis Awareness Day and National Heart Health Day we are posting a previous Mayo Clinic Q & A article that addresses this issue. DEAR MAYO CLINIC: Is it true that people with rheumatoid arthritis have a higher risk of heart disease? How are the two conditions related? Is there a way to [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - February 2, 2016 Category: Databases & Libraries Source Type: news

NICE recommends 7 drugs for rheumatoid arthritis
(Source: PharmacoEconomics and Outcomes News)
Source: PharmacoEconomics and Outcomes News - February 1, 2016 Category: Drugs & Pharmacology Source Type: news

Encouraging autonomy and self-regulation 'can help rheumatoid arthritis patients stay active'
This study shows that interventions aimed at maintaining motivation can be beneficial to people with this painful and debilitating condition." (Source: Arthritis Research UK)
Source: Arthritis Research UK - February 1, 2016 Category: Rheumatology Source Type: news

RheumNow: Risk of MS With TNF Inhibitor Therapy
(MedPage Today) -- Do standard rheumatoid arthritis drugs promote development of MS? (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - January 31, 2016 Category: Primary Care Source Type: news

Study shows long-term benefits of golimumab therapy for psoriatic arthritis
New research has demonstrated the potentially significant long-term benefits that golimumab therapy can provide for people with psoriatic arthritis.The international study, led by the University of California, San Diego, aimed to evaluate long-term outcomes in psoriatic arthritis patients who achieved or did not achieve minimal disease activity over five years of golimumab treatment.This placebo-controlled trial lasted 24 weeks and was followed by an open-label extension period of up to five years. Results from the study were published in the medical journal Arthritis Care and Research.It was shown that treatment with goli...
Source: Arthritis Research UK - January 29, 2016 Category: Rheumatology Source Type: news

Antares Pharma Announces CEO Transition
Robert Apple Appointed President and Chief Executive Officer EWING, N.J., Jan. 26, 2016 -- (Healthcare Sales & Marketing Network) -- Antares Pharma, Inc. (ATRS) today announced that its Board of Directors has appointed Robert Apple to the position of Pr... Biopharmaceuticals, PersonnelAntares Pharma, OTREXUP, methotrexate, rheumatoid arthritis (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - January 26, 2016 Category: Pharmaceuticals Source Type: news

NICE issues final guidance for rheumatoid arthritis
NICE recommends that severe rheumatoid arthritis, which has not responded to intensive therapy, is treated with a combination of conventional biological disease modifying drugs Hide related content:  Show related content read more (Source: Nursing in Practice)
Source: Nursing in Practice - January 26, 2016 Category: Nursing Authors: ltrevallion Tags: Women ' s health Care of older people Editor s pick Latest News Source Type: news

RheumNow: 10 Ways RA Could’ve Killed Glenn Frey
(MedPage Today) -- Jack Cush reviews the complications associated with rheumatoid arthritis (Source: MedPage Today Primary Care)
Source: MedPage Today Primary Care - January 22, 2016 Category: Primary Care Source Type: news

People with inflammatory arthritis let down by health service, new report shows
People with rheumatoid and early inflammatory arthritis are being let down by the health service, a new clinical audit has shown. The audit, led by the British Society of Rheumatology, found that many patients in England and Wales are experiencing long waiting times and delays. A high proportion of services weren't meeting the quality standards set by the National Institute for Health and Care Excellence (NICE), including referral from a GP within 3 days, and assessment in a rheumatology service within 3 weeks of referral. Average wait times According to the audit: only one in six patients were referred by their GP to ...
Source: Arthritis Research UK - January 22, 2016 Category: Rheumatology Source Type: news

Gut bacteria could lead to new treatment for inflammatory arthritis
Studying the trillions of bacteria and other microbes that share our body space could lead to a preventative treatment for immune diseases such as rheumatoid arthritis. It's long been suggested that the bacteria which live in our gut, mouth and elsewhere on our bodies may affect our immune system and lead to the development of certain diseases, including rheumatoid arthritis. But exactly how changes to these bacteria, collectively called the “microbiome”, cause disease remains to be discovered. The research, which we awarded £2 million to, aims to unlock the link between gut bacteria and the development o...
Source: Arthritis Research UK - January 21, 2016 Category: Rheumatology Source Type: news

Motivations for Personalized Genetic Testing Include Explaining -- Not Just Predicting
Last week, I invited the venerable Lee Hood to speak to us at Harvard Medical School, and I was reminded again of his prescience in describing and advocating for "P4 Medicine" -- or predictive, preventive, personalized and participatory medicine -- over 10 years ago, in 2004! And while Lee's vision of P4 Medicine embraces a model of systems biology that is broader than just the genome, the democratization of genetic testing over the past decade falls squarely within the powerful narrative prediction and prevention. Indeed, much of the controversy surrounding direct-to-consumer (DTC) genetic testing when it launched in 2007...
Source: Science - The Huffington Post - January 20, 2016 Category: Science Source Type: news

Lilly and Incyte Announce Submission of NDA to FDA for Oral Once-Daily Baricitinib for Treatment of Moderate-to-Severe Rheumatoid Arthritis
INDIANAPOLIS, Jan. 19, 2016 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) and Incyte Corporation (NASDAQ: INCY) today announced that Lilly has submitted a new drug application (NDA) to the U.S. Food and Drug Administration (FDA) for the approval... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - January 19, 2016 Category: Drugs & Pharmacology Source Type: news

New biosimilar version of etanercept approved in Europe
An affordable new treatment for various types of arthritis is to be made available in Europe following the approval of the drug Benepali.The new biosimilar version of the anti-TNF therapy etanercept has been granted marketing authorisation in the EU for the treatment of adults with moderate to severe rheumatoid arthritis, psoriatic arthritis, non-radiographic axial spondyloarthritis and plaque psoriasis.Developed by Samsung Bioepis, the drug is the first etanercept biosimilar to be based on the licensed product Enbrel, and will become the first subcutaneous anti-TNF biosimilar to be launched in Europe.Biosimilars are biolo...
Source: Arthritis Research UK - January 19, 2016 Category: Rheumatology Source Type: news

Textile dust exposure 'could increase rheumatoid arthritis risk'
A new study has indicated that people who work with frequent exposure to textile dust could be at an elevated risk of developing rheumatoid arthritis. Led by the Institute for Medical Research in Malaysia, in association with Sweden's Karolinska Institutet, the research looked at data from 910 Malaysian women who had been diagnosed with early-stage rheumatoid arthritis, compared with data from 910 women of similar age without the disease. The patients were asked if they had ever worked in the textile industry and been exposed to other chemicals and silica dust, factors associated with a heightened risk of rheumatoid arth...
Source: Arthritis Research UK - January 19, 2016 Category: Rheumatology Source Type: news

Predicting and Preventing the Development of RAPredicting and Preventing the Development of RA
Can we predict and prevent the development of rheumatoid arthritis? Rheumatology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 18, 2016 Category: Consumer Health News Tags: Rheumatology Journal Article Source Type: news

Samsung Gets European Approval for Enbrel Copy
Samsung Group said it has won approval from regulators to sell a near-replica of the blockbuster rheumatoid arthritis drug Enbrel in Europe. (Source: WSJ.com: Health)
Source: WSJ.com: Health - January 17, 2016 Category: Pharmaceuticals Tags: PAID Source Type: news

1 Person Left Brain Dead After Clinical Trial Of Experimental Medicine In France (UPDATE)
PARIS, Jan 15 (Reuters) - One person has been left brain dead and five others have been hospitalized after taking part in a clinical trial in France of an experimental drug made by Portuguese drug company Bial, French Health Minister Marisol Touraine said on Friday. In total, 90 people have taken part in the trial, taking some dosage of the drug aimed at tackling mood and anxiety issues, as well as movement coordination disorders linked to neurological issues, Touraine said. The six men aged 28 to 49 had been in good health until taking the oral medication at the Biotrial private facility that specializes in clinical trial...
Source: Science - The Huffington Post - January 15, 2016 Category: Science Source Type: news

Occupational textile dust exposure linked to rheumatoid arthritis
Occupational exposure to textile dust is associated with a more than doubling in the risk of developing rheumatoid arthritis, finds new research. And it is also linked to a heightened risk of genetic susceptibility to the risk of developing antibodies to rheumatoid arthritis, known as ACPA, which hasten progression of the disease. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - January 15, 2016 Category: Science Source Type: news

Medical News Today: Ovarian cancer with BRCA1 mutation may be treatable with arthritis drug
Lab tests show that auranofin - normally used to treat rheumatoid arthritis - can cut survival of ovarian cancer cells that have low levels of the DNA repair protein BRCA1. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 11, 2016 Category: Consumer Health News Tags: Ovarian Cancer Source Type: news

Arthritis drug could also help combat ovarian cancer
ConclusionThere is an ongoing need for the development of new and more effective treatments for ovarian cancer, a cancer that is notoriously detected at a late stage and often has a poor outlook as a result. Women with mutations in the DNA repair gene, BRCA1, are known to have an increased risk of developing ovarian cancer. This laboratory study investigated the potential of the drug auranofin, which is approved in the US for the treatment of rheumatoid arthritis. The researchers found auranofin had superior cancer-killing properties in ovarian cancer cells lacking BRCA1. It seems depletion of BRCA1 makes the cancer cells ...
Source: NHS News Feed - January 11, 2016 Category: Consumer Health News Tags: Cancer Medication Source Type: news

Arthritis drug could offer hope to millions with the 'Angelina Jolie gene'
Plymouth University scientists found that auranofin, a drug typically used to treat rheumatoid arthritis, can help cut survival of cancerous ovarian cells in women with BRCA1 mutations, by 37 per cent. (Source: the Mail online | Health)
Source: the Mail online | Health - January 9, 2016 Category: Consumer Health News Source Type: news

What Are the Best and Worst Supplements and Herbs for Rheumatoid Arthritis (RA)?
Some supplements are good for rheumatoid arthritis (RA). Some are dangerous. WebMD explains which supplements and herbs may help relieve rheumatoid arthritis symptoms and which ones you should never take. (Source: WebMD Health)
Source: WebMD Health - January 7, 2016 Category: Consumer Health News Source Type: news

Expert Advice on How to Treat Rheumatoid Arthritis
An expert tells WebMD how to manage and treat rheumatoid arthritis. (Source: WebMD Health)
Source: WebMD Health - January 7, 2016 Category: Consumer Health News Source Type: news

Assessing the Inhibitory Activity of Oligonucleotides on TLR7 Sensing
Aberrant sensing of self-nucleic acids by Toll-like receptor (TLR) 7, 8, or 9 is associated with several autoimmune disorders, including systemic lupus erythematosus (SLE), rheumatoid arthritis, psoriasis, or systemic sclerosis. In recent years, several classes of synthetic oligonucleotides have been shown to antagonize sensing of immunostimulatory nucleic acids by TLR7/8/9, indicating that these molecules could have therapeutic applications in such autoimmune diseases. Conversely, synthetic oligonucleotides used in therapeutic technologies such as antisense and microRNA inhibitors also have the potential to inhibit TLR7/8...
Source: Springer protocols feed by Immunology - January 7, 2016 Category: Allergy & Immunology Source Type: news

Investigating the Role of Toll-Like Receptors in Models of Arthritis
Rheumatoid arthritis (RA) is a chronic autoimmune disease characterized by persistent synovial inflammation leading to tissue destruction and progressive loss of joint function. Here we describe two methods that can be used to assess the contribution of toll-like receptors (TLRs), and their potential ligands, to RA pathogenesis. We focus on the antigen-induced model of murine arthritis and human synovial tissue explant models. Both enable detection of TLR, and TLR ligand, expression, as well as investigation of the effect of inhibition of these molecules. Each offers a unique insight into disease; with murine models allowi...
Source: Springer protocols feed by Immunology - January 7, 2016 Category: Allergy & Immunology Source Type: news

Insider’s guide to care: Doctors and dogs
Olivia and Dayton Olivia Burgess knows every nook and cranny of Boston Children’s Hospital. The 13-year-old and her parents have traveled from their home in Bermuda to Boston since Olivia was three years old for ongoing treatments for systemic onset juvenile rheumatoid (idiopathic) arthritis and pediatric lupus. “The unpredictable and severe nature of Olivia’s condition and the frequent travel required for medical treatment can be stressful at times,” says her mother Traci. Olivia sees providers in multiple departments: cardiology, nephrology, pulmonology, dermatology, neurology, gastroenterology and orthopedic sur...
Source: Thrive, Children's Hospital Boston - January 4, 2016 Category: Pediatrics Authors: Lisa Fratt Tags: Our Patients’ Stories Fatma Dedeoglu juvenile rheumatoid arthritis Marybeth Son Pawprints Program pediatric lupus rheumatology program Robert Geggel Sitaram Emani Source Type: news

Eat fish to LOWER arthritis risk
CONSUMING more omega-3 fatty acids could lower the risk of developing rheumatoid arthritis , according to new research. (Source: Daily Express - Health)
Source: Daily Express - Health - December 28, 2015 Category: Consumer Health News Source Type: news

Medical News Today: Omega-3 helps ward off rheumatoid arthritis
People who are predisposed to develop RA are less likely to develop it if they have been taking omega-3 fish oil and supplements, say researchers. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 27, 2015 Category: Consumer Health News Tags: Arthritis / Rheumatology Source Type: news